Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII
January 25, 2023 08:03 ET | Catalyst Pharmaceuticals, Inc.
Strengthens its Commercial Portfolio with the First and Only AMPA Receptor Antagonist Marketed Product for Epilepsy Bolsters Presence in Neuroscience Expected to be Accretive in 2023 ...
CryoMass' Trichome Separation system installation in California. 1
CryoMass Signs $10.2 Million Multi-State License Agreement
January 18, 2023 07:10 ET | Cryomass Technologies
DENVER, Jan. 18, 2023 (GLOBE NEWSWIRE) -- CryoMass Technologies Inc. (the “Company” or “CryoMass”) (OTCQX: CRYM) is pleased to announce the signing of a multi-state license agreement with...
Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd
December 19, 2022 16:10 ET | Catalyst Pharmaceuticals, Inc.
Acquisition Expands The Company’s Commercial Portfolio With An Established U.S. Marketed Product Company Remains Dedicated To Growth Within Neurology Through Continued Active Business Development...
Epomaker Black Friday Sale
Black Friday is Around the Corner: Epomaker Hits the Exciting November Hot-Sale Wave for Mechanical Keyboard Enthusiasts
November 25, 2022 08:00 ET | Epomaker
NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Epomaker, the professional customizable mechanical keyboards and accessories provider, launches its Hot-Sale Month campaign for the whole of November in...
vTv Graps Logo.png
vTv Therapeutics Announces Investment by CinRx Pharma
July 25, 2022 07:00 ET | vTv Therapeutics Inc.
HIGH POINT, N.C., July 25, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced entry into agreements that include a $10 million investment by CinPax, LLC (“CinPax”), a...
HillmanLogo__Black.png
Hillman Announces Upsize and Pricing of Secondary Offering of Common Stock by Selling Stockholders
April 13, 2022 07:00 ET | The Hillman Group
CINCINNATI, April 13, 2022 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, today...
Atos développe un ce
Atos développe un centre de connaissance de la situation spatiale pour les forces armées allemandes
April 04, 2022 04:15 ET | Atos International
Une nouvelle plateforme numérique pour sécuriser l'infrastructure spatiale de l'Allemagne Munich, le 4 avril 2022 - Atos et l'entreprise multinationale européenne de technologie...
Atos develops Space
Atos develops Space Situational Awareness Center for the German Armed Forces
April 04, 2022 04:15 ET | Atos International
New digital platform to secure Germany’s national space infrastructure Munich, April 4, 2022 - Atos and the European multi-national space technology company OHB have been awarded a...
Logo.jpg
Muscle Maker Signs 40 Unit Franchise Deal
November 01, 2021 08:30 ET | Muscle Maker, Inc.
Muscle Maker Grill continues rapid expansion with Saudi Arabia deal. This represents the second international agreement after 10-unit Kuwait agreement. Deal, if fully executed, could potentially...
vTv Graps Logo.png
vTv Therapeutics and Cantex Pharmaceuticals Announce Strategic Licensing Agreement for Development and Commercialization of Azeliragon for Treatment of Cancer HIGH POINT, N.C. and WESTON, Fla., June 22, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (“vTv”, Nasdaq:VTVT) and Cantex Pharmaceuticals, Inc. (“Cantex”) today announced that they have entered...